Chia Tai Enterprises International Ltd
Drug Manufacturers - Specialty & Generic
News & analysis
Times are shown in GMT+8, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
Chia Tai Enterprises International Ltd engaged in the manufacture and sale of chlortetracycline (CTC) products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and other related products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China, Asia Pacific (excluding mainland China), Americas, Europe, and Others.Chia Tai Enterprises International Ltd is a US based company operates in the Biotechnology sector. It operates through two reportable operating segments which are biochemical and Industrial segments.
Latest 3839 News